Discontinuation report FIASP
| Report ID | 240240 |
| Drug Identification Number | 02460424 |
| Brand name | FIASP |
| Common or Proper name | FIASP |
| Company Name | NOVO NORDISK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN ASPART |
| Strength(s) | 100UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 5 |
| ATC code | A10AB |
| ATC description | INSULINS AND ANALOGUES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-12-31 |
| Actual discontinuation date | |
| Remaining supply date | 2025-12-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
| Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-10-15 | French | Compare |
| v1 | 2024-10-15 | English | Compare |
Showing 1 to 2 of 2